Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our Twin Momentum Investor model based on the published strategy of ...

Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our P/B Growth Investor model based on the published strategy of ...

Antihypertensive treatment reduces LV mass (LVM). However, interindividual variation in LV traits in response to antihypertensive treatments exists. We hypothesized that genetic variants may modify ...

Targeted resequencing of DNA allows researchers to focus on genes of interest for cost-effective analysis of genetic variations. Typically, to analyze single nucleotide mutations and copy number ...

This is a technical analysis article. Our “Implied Return” computer program picked Synopsys, Inc. stock for us, and we added it to our 2024 Model Portfolio. The computer uses both technical and ...

This discrepancy between valuation and performance may suggest that investing in ORCL and CRM stocks is preferable to buying ...

Synopsys is a market leader in EDA and IP, benefiting from secular chip trends, but current valuation is 30% above intrinsic value. The Ansys acquisition is a transformational catalyst, expanding SNPS ...

Milliman’s analysis of SNP Alliance member organization risk score data from CMS suggests that while the impact of the new risk score model will vary significantly by plan and by MA organization, it ...